XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.340
-0.010 (-0.43%)
Mar 10, 2026, 11:46 AM EDT - Market open

XBiotech Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
147.37172.68200.02157.31236.98237.37
Short-Term Investments
---60.17--
Cash & Short-Term Investments
147.37172.68200.02217.48236.98237.37
Cash Growth
-19.52%-13.67%-8.03%-8.23%-0.16%-66.78%
Accounts Receivable
-----4.11
Other Receivables
0.530.860.941.768.9581.64
Total Trade Receivables
0.530.860.941.768.9585.75
Other Current Assets
1.061.030.760.60.932.76
Total Current Assets
148.95174.57201.72219.84246.87325.88
Net Property, Plant & Equipment
23.4724.5324.926.2628.3127.34
Other Long-Term Assets
-----0.53
Total Assets
172.42199.09226.62246.1275.18353.74
Accounts Payable
1.042.222.522.412.072.49
Accrued Expenses
2.422.633.51.61.371.35
Short-Term Debt
-10.25----
Other Current Liabilities
0.1-0.080.060.010.14
Total Current Liabilities
3.5715.116.14.073.453.98
Other Long-Term Liabilities
1.781.721.671.642.341.12
Total Long-Term Liabilities
1.781.721.671.642.341.12
Total Liabilities
5.3416.837.775.75.795.11
Common Stock
276.57273.11271.15267.33262.26249.81
Accumulated Other Comprehensive Income
---0.831.971.27
Retained Earnings
-109.49-90.84-52.31-27.755.1597.57
Shareholders' Equity
167.08182.27218.85240.4269.39348.64
Total Liabilities & Equity
172.42199.09226.62246.1275.18353.74
Total Debt
-10.250000
Net Cash (Debt)
147.37162.43200.02217.48236.98237.37
Net Cash Growth
-9.27%-18.80%-8.03%-8.23%-0.16%-66.78%
Net Cash Per Share
4.835.336.575.727.897.70
Book Value
167.08182.27218.85240.4269.39348.64
Book Value Per Share
5.485.987.196.338.9711.31
Tangible Book Value
167.08182.27218.85240.4269.39348.64
Tangible Book Value Per Share
5.485.987.196.338.9711.31
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q